GWLL — GOLDENWELL BIOTECH, INC.

OTC · Consumer Staples · Food Products · CIK 1800373 ·
Last close
Market Cap
52W High
52W Low
ADV30
Next earnings
Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. It is developing JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement. The company was incorporated in 2019 and is based in Hudson, Ohio.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Sep 2025 25,000 25,000 -5,885 -7,985 220,410 45,622 315,232
Jun 2025 37,500 37,500 -3,120 -5,220 251,295 76,507 338,132
Mar 2025 0 0 -32,277 -34,377 191,915 17,127 273,533
Dec 2024 -158 -85 -19,136 -27,536 224,192 49,404 271,433

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-22,833
Investing CF
Financing CF
$63,700
CapEx
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.00
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,407,226
Inventory
$174,788
Receivables
$0
ST Investments
EBIT TTM
$-60,418
Pretax Income TTM
$-75,118
Interest Exp TTM
$8,400
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$62,342
EBITDA
Free Cash Flow
$-8,897
Enterprise Value
$98,735,248
Total Cash
$45,622
Total Debt
$275,873
Shares Out
99,000,000
Trailing EPS
$0.00
Book Value
$-0.00
ROE
ROA
-20.2%
Div Yield

Annual Trend (SEC EDGAR, last 3y)

Revenues vs Net Income (last 3y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2024 139 -123,098 -131,498 224,192 271,433 -123,077
Dec 2023 1,836 -115,826 -117,361 228,094 143,837 -113,153
Dec 2022 47,800 -985,105 -985,097 248,400 46,782 -1,072,560

Peers — same industry

TickerNameMarket CapLastDaily %
KO COCA COLA CO $346.18B $80.46
PM Philip Morris International Inc. $282.93B $181.53
PEP PEPSICO INC $199.11B $145.68
BUD Anheuser-Busch InBev SA/NV $141.36B $82.46
BTI British American Tobacco p.l.c. $140.43B $64.94

Recent Insider Activity

No insider activity indexed for this ticker.